BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27306910)

  • 1. Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
    Streff H; Profato J; Ye Y; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
    Oncologist; 2016 Jul; 21(7):869-74. PubMed ID: 27306910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
    Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proven non-carriers in BRCA families have an earlier age of onset of breast cancer.
    Vos JR; de Bock GH; Teixeira N; van der Kolk DM; Jansen L; Mourits MJ; Oosterwijk JC
    Eur J Cancer; 2013 Jun; 49(9):2101-6. PubMed ID: 23490645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
    Antoniou A; Pharoah PD; Narod S; Risch HA; Eyfjord JE; Hopper JL; Loman N; Olsson H; Johannsson O; Borg A; Pasini B; Radice P; Manoukian S; Eccles DM; Tang N; Olah E; Anton-Culver H; Warner E; Lubinski J; Gronwald J; Gorski B; Tulinius H; Thorlacius S; Eerola H; Nevanlinna H; Syrjäkoski K; Kallioniemi OP; Thompson D; Evans C; Peto J; Lalloo F; Evans DG; Easton DF
    Am J Hum Genet; 2003 May; 72(5):1117-30. PubMed ID: 12677558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
    Mersch J; Jackson MA; Park M; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
    Cancer; 2015 Jan; 121(2):269-75. PubMed ID: 25224030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers.
    Ko KP; Kim SJ; Huzarski T; Gronwald J; Lubinski J; Lynch HT; Armel S; Park SK; Karlan B; Singer CF; Neuhausen SL; Narod SA; Kotsopoulos J;
    Int J Cancer; 2018 Jun; 142(11):2263-2272. PubMed ID: 29330845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between BRCA1 mutations and ratio of female to male births in offspring of families with breast cancer, ovarian cancer, or both.
    de la Hoya M; Fernández JM; Tosar A; Godino J; Sánchez de Abajo A; Vidart JA; Pérez-Segura P; Díaz-Rubio E; Caldés T
    JAMA; 2003 Aug; 290(7):929-31. PubMed ID: 12928470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status.
    Loman N; Bladström A; Johannsson O; Borg A; Olsson H
    Breast Cancer Res; 2003; 5(6):R175-86. PubMed ID: 14580253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Fan I; Tang J; Li S; Zhang S; Shaw PA; Narod SA
    J Natl Cancer Inst; 2006 Dec; 98(23):1694-706. PubMed ID: 17148771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.
    Lorenzo Bermejo J; Hemminki K
    Ann Oncol; 2004 Dec; 15(12):1834-41. PubMed ID: 15550590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counseling for male BRCA mutation carriers: a review.
    Mohamad HB; Apffelstaedt JP
    Breast; 2008 Oct; 17(5):441-50. PubMed ID: 18657973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy.
    Pearson EJ; Nair A; Daoud Y; Blum JL
    Breast Cancer Res Treat; 2017 Feb; 162(1):59-67. PubMed ID: 28066861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations.
    Dite GS; Whittemore AS; Knight JA; John EM; Milne RL; Andrulis IL; Southey MC; McCredie MR; Giles GG; Miron A; Phipps AI; West DW; Hopper JL
    Br J Cancer; 2010 Sep; 103(7):1103-8. PubMed ID: 20877337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients.
    Landsbergen K; Verhaak C; Kraaimaat F; Hoogerbrugge N
    Fam Cancer; 2005; 4(2):115-9. PubMed ID: 15951961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?
    Semple J; Metcalfe KA; Lubinski J; Huzarski T; Gronwald J; Armel S; Lynch HT; Karlan B; Foulkes W; Singer CF; Neuhausen SL; Eng C; Iqbal J; Narod SA;
    Breast Cancer Res Treat; 2015 Nov; 154(1):163-9. PubMed ID: 26467043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.